Denosumab
Brands: Bomyntra · Conexxence · Jubbonti · Prolia +2 · Denosumab
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Bomyntra · Conexxence · Jubbonti · Prolia +2 · Denosumab
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amgen, Inc | unknown | 4 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 3 | SUPPLYING |
| Sandoz Inc | generic | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations; potential temperature excursions due to transit delays — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — Within the U.S - OH, VA, FL.
Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination. — Recalling firm: Amgen, Inc. — Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.